On Tuesday, Organogenesis Holdings Inc (NASDAQ: ORGO) opened at On Tuesday, remained unchanged from the last session, before settling in for the closing price of $2.99. Price fluctuations for ORGO have ranged from $1.96 to $4.70 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 19.04% over the last five years. Company’s average yearly earnings per share was noted -293.41% at the time writing. With a float of $77.76 million, this company’s outstanding shares have now reached $131.32 million.
The firm has a total of 862 workers. Let’s measure their productivity. In terms of profitability, gross margin is 72.43%, operating margin of 3.07%, and the pretax margin is -2.91%.
Organogenesis Holdings Inc (ORGO) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Organogenesis Holdings Inc is 41.34%, while institutional ownership is 47.53%. The most recent insider transaction that took place on Jan 09 ’24, was worth 863,985. In this transaction 10% Owner of this company sold 197,921 shares at a rate of $4.37, taking the stock ownership to the 59,025,106 shares. Before that another transaction happened on Jan 10 ’24, when Company’s 10% Owner sold 17,972 for $4.28, making the entire transaction worth $76,875. This insider now owns 59,007,134 shares in total.
Organogenesis Holdings Inc (ORGO) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -293.41% per share during the next fiscal year.
Organogenesis Holdings Inc (NASDAQ: ORGO) Trading Performance Indicators
Check out the current performance indicators for Organogenesis Holdings Inc (ORGO). In the past quarter, the stock posted a quick ratio of 2.42. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.88. Likewise, its price to free cash flow for the trailing twelve months is 46.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.13, a number that is poised to hit -0.02 in the next quarter and is forecasted to reach -0.08 in one year’s time.
Technical Analysis of Organogenesis Holdings Inc (ORGO)
Analysing the last 5-days average volume posted by the [Organogenesis Holdings Inc, ORGO], we can find that recorded value of 0.3 million was lower than the volume posted last year of 0.86 million. As of the previous 9 days, the stock’s Stochastic %D was 80.21%. Additionally, its Average True Range was 0.15.
During the past 100 days, Organogenesis Holdings Inc’s (ORGO) raw stochastic average was set at 71.36%, which indicates a significant decrease from 72.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 48.26% in the past 14 days, which was lower than the 56.59% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.76, while its 200-day Moving Average is $2.99. Now, the first resistance to watch is $3.07. This is followed by the second major resistance level at $3.15. The third major resistance level sits at $3.23. If the price goes on to break the first support level at $2.91, it is likely to go to the next support level at $2.83. Now, if the price goes above the second support level, the third support stands at $2.75.
Organogenesis Holdings Inc (NASDAQ: ORGO) Key Stats
There are currently 132,572K shares outstanding in the company with a market cap of 396.38 million. Presently, the company’s annual sales total 433,140 K according to its annual income of 4,950 K. Last quarter, the company’s sales amounted to 130,230 K and its income totaled -17,040 K.
